Showing results (101-110 of 144) with videos related to

Sort By:
Pageof 15
Frontiers in Immunology|January 2, 2026
Real-world effectiveness of vedolizumab in refractory pouchitis: a focus on biomarker changes during intravenous to subcutaneous transition (POUCHIVED study)Leticia Gimeno-Pitarch, Elena Céspedes-Martínez, Rocío Ferreiro-Iglesias, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|December 28, 2022
Should Inflammatory Bowel Disease Clinicians Provide Their Patients with e-Health Resources? Patients' and Professionals' PerspectivesAna Echarri, José L Pérez-Calle, Marta Calvo, et al.
Gastroenterologia Y Hepatologia|September 25, 2021
Psychosocial impact of the COVID-19 pandemic on patients with inflammatory bowel disease in Spain. A post lockdown reflectionAlejandro Hernández Camba, Laura Ramos, María Blanca Madrid Álvarez, et al.
The Lancet. Gastroenterology & Hepatology|November 21, 2024
Vedolizumab to prevent postoperative recurrence of Crohn's disease (REPREVIO): a multicentre, double-blind, randomised, placebo-controlled trialGeert D'Haens, Carlos Taxonera, Antonio Lopez-Sanroman, et al.
BMC Medicine|September 10, 2016
Urine metabolome profiling of immune-mediated inflammatory diseasesArnald Alonso, Antonio Julià, Maria Vinaixa, et al.
Gastroenterologia Y Hepatologia|December 13, 2024
Position statement of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis on the use of Telemedicine in Inflammatory Bowel DiseaseMariam Aguas Peris, Javier Del Hoyo Francisco, Pilar Nos Mateu, et al.
The American Journal of Gastroenterology|January 13, 2016
Diagnostic Performance of the Simple Clinical Colitis Activity Index Self-Administered Online at Home by Patients With Ulcerative Colitis: CRONICA-UC StudyIgnacio Marín-Jiménez, Pilar Nos, Eugeni Domènech, et al.
Scientific Reports|October 21, 2020
Real-life experience with 4 years of golimumab persistence in ulcerative colitis patientsMarisa Iborra, Natalia García-Morales, Saoia Rubio, et al.
Therapeutic Advances in Gastroenterology|June 18, 2019
EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in SpainMaría Chaparro, Manuel Barreiro-de Acosta, José Manuel Benítez, et al.
Pageof 15